Vaccines for Immune Mediated Diseases

Patients with immune-mediated inflammatory diseases (IMID) such as RA, IBD or psoriasis, are at increased risk of infection, partially because of the disease itself, but mostly because of treatment with immune-modulatory or immunosuppressive drugs. In spite of their elevated risk for vaccine-preventable disease, vaccination coverage in IMID patients is surprisingly low. Although the reduced quality of the immune response in patients under immunotherapy may have a negative impact on vaccination efficacy in this population, adequate humoral response to vaccination in IMID patients has been demonstrated for Hepatitis B, Influenza and Pneumococcal vaccination.

 

    Related Conference of Vaccines for Immune Mediated Diseases

    April 15-16, 2021

    Tumor & Cancer Immunology and Pediatric-Oncology

    Toronto, Canada
    May 03-04, 2021

    International Online Conference on Immunology

    New York, USA
    May 06-06, 2021

    3rd International Conference on Dermatology and Allergic Diseases

    Singapore City, Singapore
    May 06-07, 2021

    9th World Summit on immunology & immunotherapy

    Prague, Czech Republic
    June 23-24, 2021

    34th World Congress on Vaccines and Immunization

    Osaka, Australia
    August 27-28, 2021

    5th International Conference on Emerging Infectious Diseases

    Amsterdam, Netherlands
    October 12-13, 2021

    International Conference on Vaccine and Vaccine research

    Manila, Philippines
    October 14-15, 2021

    13th Annual Conference on Cinical Immunology

    Cape Town, Australia
    October 14-15, 2021

    11th International Conference on Bacteriology and Infectious Diseases

    Cape Town, South Africa
    November 10-11, 2021

    International Conference on Immunology Research

    New York, USA

    Vaccines for Immune Mediated Diseases Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in